Premium
Agenus Inc (AGEN)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Agenus Inc is an American biotechnology company. Its main target is immuno-oncology treatments. The company's portfolio consists of therapeutic antibodies and vaccines to treat immuno-oncology illnesses: cancers, shingles, malaria, glioblastoma, and others. Agenus treatments aim, by combining multip... Agenus Inc is an American biotechnology company. Its main target is immuno-oncology treatments. The company's portfolio consists of therapeutic antibodies and vaccines to treat immuno-oncology illnesses: cancers, shingles, malaria, glioblastoma, and others. Agenus treatments aim, by combining multiple antibody platforms, to stimulate the immune system to recognize and fight cancer cells. The company has been cooperating with companies like Incyte, Merck Sharpe & Dohme, and Recepta Biopharma to achieve over a dozen antibody programs. Some of its products include Prophage, AutoSynVax, QS-21 Stimulon, and others. Show more
Presentations will showcase new data reinforcing BOT/BAL’s potential across different lines of treatment in colorectal cancer, including the neoadjuvant setting Agenus Inc. (Nasdaq: AGEN), a...
Agenus Inc., a leader in immuno-oncology, today announced further details of its strategic realignment aimed at streamlining operations, strengthening its financial position, and prioritizing the...
Agenus Inc. (“Agenus” or the “Company”) (Nasdaq: AGEN), an immuno-oncology company focused on innovation has successfully secured a $22 million non-amortizing mortgage backed by its...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.27 | -8.70967741935 | 3.1 | 3.1436 | 2.65 | 478370 | 2.85830393 | CS |
| 4 | 0.04 | 1.43369175627 | 2.79 | 4.06 | 2.65 | 579579 | 3.31037072 | CS |
| 12 | -2.36 | -45.472061657 | 5.19 | 5.81 | 2.5 | 502114 | 3.63956548 | CS |
| 26 | -10.12 | -78.1467181467 | 12.95 | 18.74 | 2.5 | 596894 | 6.22864283 | CS |
| 52 | -12.37 | -81.3815789474 | 15.2 | 19.688 | 2.5 | 3669921 | 12.47219206 | CS |
| 156 | -66.57 | -95.9221902017 | 69.4 | 72.4 | 2.5 | 4664335 | 30.83243585 | CS |
| 260 | -73.77 | -96.3054830287 | 76.6 | 135.8 | 2.5 | 4118819 | 46.97030796 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
